Dr. Shyamali Singhal - Surgical Oncologist - General Surgeon - 650-641-7861
Shyamali Mallick Singhal, MD, PhD, FACS
Surgical Oncologist - Society of Surgical Oncologists Fellowship
General Surgeon - ABMS Board Certified:
Founding Director - El Camino Hospital Cancer Center
General Surgeon - ABMS Board Certified:
Founding Director - El Camino Hospital Cancer Center
Dr. Singhal is originally from San Mateo and went to Baltimore to receive her undergraduate degree in Biophysics at Johns Hopkins University. She then attended the Albert Einstein College of Medicine in New York where she completed her M.D. program while also receiving a Ph.D. in Molecular Pharmacology.
Dr. Singhal has extensive training in the cellular and molecular bases for cancer as well as the chemo, radiological, and surgical treatment of the disease. It provides Dr. Singhal a comprehensive view of cancer and a better opportunity to treat the disease.
When Dr. Singhal was completing her residency, she was amazed by the incredible improvement that complex surgery could have on health of cancer patients. This inspired her to focus her medical career on surgical oncology. She went on to complete a fellowship in Surgical Oncology at the City of Hope National Cancer Center, a leader in Minimally Invasive Surgical Oncology (MISO). Her research there focused on discovering the interactions of chemotherapy and a wide spectrum of natural agents, and the impact on liver function. She completed her Surgical Residency at the University of Washington in Seattle in one of the nation’s top surgical training programs. Dr. Singhal completed her MD and PhD from the Albert Einstein College of Medicine in New York. She completed her PhD there in the department of Molecular Pharmacology with the thesis, Studies in the Regulation of the mdr1b gene by Progesterone.
Awards:
· America's Top Surgeons - from the Consumer Research Council of America
· Patient's Choice - Surgeon - from the Patient's Choice Organization
· YWCA Leadership Award - from the TWIN (Tribute to Women) YWCA
Appointments:
· ACS Board of Directors, SCC Region
· Susan G. Komen Foundation LA Chapter, Co-chair Education Committee 2003-05
Professional & Academic Societies:
· Society of Surgical Oncology
· American College of Surgeons, Fellow
· American Society of Clinical Oncologists
· Alpha Omega Alpha(MD honor society)
· Harkins Society-University of Washington
Education:
City of Hope National Medical Center, Duarte (Los Angeles), CA
Surgical Oncology Fellowship, 2002-2005
University of Washington, Seattle, WA
Surgical Residency
Internship 1997-1998
Residency 1998-2002
AlbertEinstein College of Medicine, Bronx, NY
M.D. 1997
Ph.D. Molecular Pharmacology, 1995
Ph.D. Thesis: Studies in the Regulation of the mdr1b gene by Progesterone
Johns Hopkins University, Baltimore, MD
B.A. Biophysics, 1987
Research Experience:
Post-Doctoral Fellow, Beckman Research Institute, City of Hope, Dr. Barry Forman Lab. Duarte (Los Angeles), CA. 2002-2005
R&D Chemist, Applied Biosystems, Foster City, CA; DNA Sequencing R&D. Developed DNA standards for 1st DNA sequencer. 1986, 1987-1988, 1990
Research Technician II, HHMI, Stanford University, CA. 1988-1989
Research Intern, Johns Hopkins University, Dr. Robert J. Maier Lab. 1985-1987
Selected Publications:
Mallick, S. and Horwitz, S.B.. Transcriptional regulation of the murine multidrug resistance gene, mdr1b, by progesterone occurs via an indirect mechanism. DNA Cell Biol: 16(7) 807-818. 1997
Mallick, S. and Horwitz, S.B.. "A Role for Progesterone in Multidrug Resistance" in Estrogens and Progestins and their Antagonists in Health and Disease. Volume 2. pp123--151. 1996
Kuo, D., Mallick, S., Shen, H-J., DeVictoria, C., Jones, J., Fields, A., Goldberg, G., Runowicz, C., and Susan Band Horwitz. Quantitative analysis of multidrug resistance gene (MDR1) expression in endometrial cancer and benign endometrium using the method of reverse transcription polymerase chain reaction (RT-PCR) Clinical Cancer 2:1981-1992. 1996
Heiner, C., Mallick, S., Wan, A., Hunkapillar, M.. Taq polymerase: Increased versatility in DNA Sequencing. Applied Biosystems, User Bulletin #10, 1988
Stults, L., Mallick, S., and Maier, R. J.. Nickel uptake in B. japonicum. J. Bacteriol. (1987) 169: 1398-1402
Presentations:
Mallick, Shyamali. Activation of Hepatic Clearance mechanisms by herbal agents. COH Symposium March 2003
Mallick, S., Canty, T. and Meissner, M.. Mesenteric venous ischemia as a result of hypercoagulable states. Pacific Vascular Society Mtg. Couer D’Alene, ID. 2000
Mallick, S., Canty, T. and Meissner, M.. Hypercoagulable states as a cause of mesenteric ischemia. ACS- Washington State Chapter Mtg. Lake Chelan WA. 2000
Mallick, Shyamali. Mesenteric Venous Thrombosis resulting from Hypercoagulable states: Three Case Reports and Review of the Literature. GI Grand Rounds March 2000
Mallick, Shyamali. DIC in the multiple trauma patient. Trauma Conference February 2000
Mallick, Shyamali. Traumatic iliac arterial injuries. Trauma Conference November 2001
Mallick, Shyamali. Transmediastinal gunshot wounds. Trauma Conference March 2002
Dr. Singhal has extensive training in the cellular and molecular bases for cancer as well as the chemo, radiological, and surgical treatment of the disease. It provides Dr. Singhal a comprehensive view of cancer and a better opportunity to treat the disease.
When Dr. Singhal was completing her residency, she was amazed by the incredible improvement that complex surgery could have on health of cancer patients. This inspired her to focus her medical career on surgical oncology. She went on to complete a fellowship in Surgical Oncology at the City of Hope National Cancer Center, a leader in Minimally Invasive Surgical Oncology (MISO). Her research there focused on discovering the interactions of chemotherapy and a wide spectrum of natural agents, and the impact on liver function. She completed her Surgical Residency at the University of Washington in Seattle in one of the nation’s top surgical training programs. Dr. Singhal completed her MD and PhD from the Albert Einstein College of Medicine in New York. She completed her PhD there in the department of Molecular Pharmacology with the thesis, Studies in the Regulation of the mdr1b gene by Progesterone.
Awards:
· America's Top Surgeons - from the Consumer Research Council of America
· Patient's Choice - Surgeon - from the Patient's Choice Organization
· YWCA Leadership Award - from the TWIN (Tribute to Women) YWCA
Appointments:
· ACS Board of Directors, SCC Region
· Susan G. Komen Foundation LA Chapter, Co-chair Education Committee 2003-05
Professional & Academic Societies:
· Society of Surgical Oncology
· American College of Surgeons, Fellow
· American Society of Clinical Oncologists
· Alpha Omega Alpha(MD honor society)
· Harkins Society-University of Washington
Education:
City of Hope National Medical Center, Duarte (Los Angeles), CA
Surgical Oncology Fellowship, 2002-2005
University of Washington, Seattle, WA
Surgical Residency
Internship 1997-1998
Residency 1998-2002
AlbertEinstein College of Medicine, Bronx, NY
M.D. 1997
Ph.D. Molecular Pharmacology, 1995
Ph.D. Thesis: Studies in the Regulation of the mdr1b gene by Progesterone
Johns Hopkins University, Baltimore, MD
B.A. Biophysics, 1987
Research Experience:
Post-Doctoral Fellow, Beckman Research Institute, City of Hope, Dr. Barry Forman Lab. Duarte (Los Angeles), CA. 2002-2005
R&D Chemist, Applied Biosystems, Foster City, CA; DNA Sequencing R&D. Developed DNA standards for 1st DNA sequencer. 1986, 1987-1988, 1990
Research Technician II, HHMI, Stanford University, CA. 1988-1989
Research Intern, Johns Hopkins University, Dr. Robert J. Maier Lab. 1985-1987
Selected Publications:
Mallick, S. and Horwitz, S.B.. Transcriptional regulation of the murine multidrug resistance gene, mdr1b, by progesterone occurs via an indirect mechanism. DNA Cell Biol: 16(7) 807-818. 1997
Mallick, S. and Horwitz, S.B.. "A Role for Progesterone in Multidrug Resistance" in Estrogens and Progestins and their Antagonists in Health and Disease. Volume 2. pp123--151. 1996
Kuo, D., Mallick, S., Shen, H-J., DeVictoria, C., Jones, J., Fields, A., Goldberg, G., Runowicz, C., and Susan Band Horwitz. Quantitative analysis of multidrug resistance gene (MDR1) expression in endometrial cancer and benign endometrium using the method of reverse transcription polymerase chain reaction (RT-PCR) Clinical Cancer 2:1981-1992. 1996
Heiner, C., Mallick, S., Wan, A., Hunkapillar, M.. Taq polymerase: Increased versatility in DNA Sequencing. Applied Biosystems, User Bulletin #10, 1988
Stults, L., Mallick, S., and Maier, R. J.. Nickel uptake in B. japonicum. J. Bacteriol. (1987) 169: 1398-1402
Presentations:
Mallick, Shyamali. Activation of Hepatic Clearance mechanisms by herbal agents. COH Symposium March 2003
Mallick, S., Canty, T. and Meissner, M.. Mesenteric venous ischemia as a result of hypercoagulable states. Pacific Vascular Society Mtg. Couer D’Alene, ID. 2000
Mallick, S., Canty, T. and Meissner, M.. Hypercoagulable states as a cause of mesenteric ischemia. ACS- Washington State Chapter Mtg. Lake Chelan WA. 2000
Mallick, Shyamali. Mesenteric Venous Thrombosis resulting from Hypercoagulable states: Three Case Reports and Review of the Literature. GI Grand Rounds March 2000
Mallick, Shyamali. DIC in the multiple trauma patient. Trauma Conference February 2000
Mallick, Shyamali. Traumatic iliac arterial injuries. Trauma Conference November 2001
Mallick, Shyamali. Transmediastinal gunshot wounds. Trauma Conference March 2002
Dr. Shyamali Singhal - General Surgery and Advanced Surgery. Specializing in Surgical Oncology for the treatment of Cancer - Melanoma (Skin Cancer), Colon Cancer, Stomach Cancer, Liver Cancer, Pancreatic Cancer, Breast Cancer, etc. Experienced Whipple Procedure Surgeon.
Serving Silicon Valley - Mountain View, Los Altos, Palo Alto, Sunnyvale, Santa Clara, Saratoga, Cupertino, San Jose, Campbell and the San Francisco Bay Area - Menlo Park, East Palo Alto, Redwood City, Belmont, San Mateo, Burlingame, Millbrae, Daly City, San Francisco, South San Francisco
